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a b s t r a c t
For the ﬁrst time in Europe, both European-wide and country-speciﬁc levels of urinary Bisphenol A (BPA)
were obtained through a harmonized protocol for participant recruitment, sampling and quality
controlled biomarker analysis in the frame of the twin projects COPHES and DEMOCOPHES. 674 child-
mother pairs were recruited through schools or population registers from six European member states
(Belgium, Denmark, Luxembourg, Slovenia, Spain and Sweden). Children (5–12 y) and mothers donated
a urine sample. Information on socio-demographic characteristics, life style, dietary habits, and
educational level of the parents was provided by mothers. After exclusion of urine samples with
creatinine values below 300 mg/L or above 3000 mg/L, 653 children and 639 mothers remained for
which BPAwas measured. The geometric mean (with 95% conﬁdence intervals) and 90th percentile were
calculated for BPA separately in children and in mothers and were named “European reference values”.
After adjustment for confounders (age and creatinine), average exposure values in each country were
compared with the mean of the “European reference values” by means of a weighted analysis of
variance. Overall geometric means of all countries (95% CI) adjusted for urinary creatinine, age and
gender were 2.04 (1.87–2.24) mg/L and 1.88 (1.71–2.07) mg/L for children (n¼653) and mothers (n¼639),
respectively. Multiple regression analysis was used to identify signiﬁcant environmental, geographical,
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personal or life style related determinants. Consumption of canned food and social class (represented by
the highest educational level of the family) were the most important predictors for the urinary levels of
BPA in mothers and children. The individual BPA levels in children were signiﬁcantly correlated with the
levels in their mothers (r¼0.265, po0.001), which may suggest a possible common environmental/
dietary factor that inﬂuences the biomarker level in each pair. Exposure of the general European
population was well below the current health-based guidance values and no participant had BPA values
higher than the health-based guidance values.
& 2014 Elsevier Inc. All rights reserved.
1. Introduction
Bisphenol-A (BPA) is used in the manufacturing of plastics,
mostly polycarbonate (used in food contact materials and many
other plastic consumer products) and epoxy resins used in the
coating of food and drink cans. Other typical application areas are
paints, varnishes, glues, or thermal paper used for receipts (Geens
et al., 2011, 2012). Due to the widespread use in plastics and other
consumer products, human exposure to BPA occurs for every
individual (Geens et al., 2012). BPA is rapidly metabolized in the
human body and is quickly eliminated in urine, where it can be
measured at mg/L levels (Geens et al., 2012). Urinary BPA provides
thus a measure of recent exposure, i.e. the last few hours up to a
couple of days. However, BPA metabolism and half-life are depen-
dent on the routes of exposure. Rapid metabolism is observed for
oral exposure, while other types of exposure (which avoid ﬁrst
pass liver metabolism) may result in longer residence time of BPA
in the blood stream (Vandenberg et al., 2007)
Current exposure levels to BPA in the general population are
relatively low, with geometric means or medians of o0.1 mg/kg
body weight per day for the total intake of BPA calculated from
biomonitoring data in different countries (summarized in Geens
et al. (2012)). These BPA intakes are well below the current
tolerable daily intake (TDI) of 50,000 ng/kg body weight (bw)
per day as established by the European Food Safety Authority
(EFSA). Recently, EFSA has launched an open consultation on its
draft opinion on the potential health risks of BPA (EFSA, 2014). This
includes a temporary reduction of the TDI (t-TDI) to 5000 ng/kg
bw per day and the consideration of exposure to BPA from both
dietary and non-dietary sources.
However, human health effects from low-level exposure to BPA
remain under discussion; whether continuous exposure to BPA
may affect the hormonal system (as so act as an endocrine-
disruptor chemical) is currently being debated (Hengstler et al.,
2011; Teeguarden and Hanson-Drury, 2013; EFSA, 2014). Yet, more
research is needed to assess the health effects of long-term
exposure to low levels of BPA.
A centrally developed protocol to perform a human biomoni-
toring (HBM) feasibility study at European level on mercury,
cotinine, cadmium, phthalates and BPA in 6–11 year old children
and their mothers was developed as part of the COPHES FP7
project (Becker et al., 2014). The protocol was translated and
applied in 17 European countries in the DEMOCOPHES LIFEþ
project, the pilot study to perform HBM in Europe via a harmo-
nized approach (Casteleyn et al., 2014). Rigorous quality assess-
ment and assurance within COPHES/DEMOCOPHES guaranteed the
accuracy and international comparability of analytical results
(Schindler et al., 2014). The results of the central analysis and
their interpretation of BPA levels obtained in 6 out of the 17
countries implementing DEMOCOPHES are presented in the
current paper.
This paper presents exposure levels of BPA in and within
Europe obtained via harmonized HBM, basic data on the distribu-
tion of BPA among selected sub-groups of the general population,
along with the major determinants of exposure and the relation-
ship of measured BPA levels to guidance values.
2. Materials and methods
2.1. Study population
BPA was included as an optional biomarker in the DEMOCOPHES project and
was measured in six member states, i.e. in Belgium, Denmark, Luxembourg,
Slovenia, Spain, and Sweden. A cross-sectional study was designed to assess
exposure in a pre-determined number of children and their mothers per country
and from two areas per country with differing degrees of urbanization. Since the
selected populations are not representative for their country, the results of BPA can
thus not be considered as European reference values and should be interpreted
within the limitations of the study design. However, they provide a ﬁrst estimate of
the exposure in European children and their mothers, and will therefore be
referred to as preliminary European reference values. Originally, the two target
populations were children (age group of 6–11 years) and their accompanying
mothers, representing, with a few exceptions, women of childbearing age (up to 45
years of age). A small number of mothers were over 45 years due to difﬁculties to
reach the target sample size in some countries.
Within each country, the target sample size was 240 participants, i.e. 120
children and 120 mothers, except in Luxembourg where the target was set at 120
subjects (60 children and 60 mothers) because of its small population size.
Inclusion criteria were the following: i) both mother and child needed sufﬁcient
language ability in the national language in order to understand the study protocol
and to be able to ﬁll in the questionnaires; ii) both mother and child had to live in
the study area for at least ﬁve years; iii) the child should live with the mother for
the majority of the time (416 days/month), and iv) only one child per mother
(randomly selected) could be included in the study. Exclusion criteria were the
following: i) mothers or children living in hospitals, institutions or being homeless;
ii) mothers or children having metabolic disturbances or abnormal urine excretion.
Mother–child pairs were recruited from two different study areas selected
according to the degree of urbanization using the upper and lower categories
within a country; thus leading to the selection of a densely populated area, which is
referred to as the ‘urban area’, and an area with low population density, the so-
called ‘rural area’. The children were the primary target group, and therefore
selection was done at the level of the child. Each country had the option either to
select the children through the population registries, or to contact the children via
their schools. Five of the six countries recruited participants through schools; one
country used both population registries and schools. All participants gave informed
consent and the human subjects' approval was obtained by each involved institute.
All ﬁrst-morning urine samples were collected between September 2011 and
February 2012 in urinary vessels, prewashed with 10% nitric acid. All countries
were instructed to collect complete urine samples in one container and selected the
appropriate size of urine container for this purpose. Urine samples were kept at
4–8 1C during the ﬁeld work, aliquoted within 24 h and stored at 20 1C until
analysis. Questionnaire information on personal characteristics and exposure
pathways of the child and the mother was obtained in an in-person interview
with the mother, either during a home visit or at the examination center.
2.2. Analysis and quality assurance
Per country, urine samples were analyzed in one laboratory which used
methods validated in-house and participated in the COPHES/DEMOCOPHES Exter-
nal Quality Assessment exercises. Interlaboratory Comparison Investigation (ICI)
exercises were organized for the measurement of BPA in urine to allow the
harmonization of analytical methods and to improve the results' comparability.
Laboratories reported their results in around ﬁve weeks after receiving the test
samples and, after the evaluation by COPHES QAU (Quality Assurance Unit), the
results were discussed through a web conference with all participants. BPA was
incorporated in the ICI/EQUAS scheme during the 2nd ICI round (02/2011) from
May to July 2011. BPA was further evaluated in the 3rd ICI round (03/2011), which
was an External Quality Assessment (EQUAS 1) and took place from September to
November 2011 and in the EQUAS 2 (December 2011 to February 2012). In order to
be accepted as DEMOCOPHES lab to perform the analyses of BPA in urine samples,
the laboratories had to successfully participate in at least one ICI and one EQUAS or
two EQUAS rounds. In both EQUAS 1 and EQUAS 2 performed during the
measurement campaign of DEMOCOPHES, the RSDs of the qualiﬁed labs (n¼5)
were 20.5% and 13.5% for the low conc. control samples (1.48 mg/L and 3.01 mg/L,
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respectively) and 17.8% and 19.0% for the high conc. control samples (35.6 mg/L and
11.9 mg/L, respectively).
Among laboratories which have qualiﬁed to analyzed BPA in the DEMOCOPHES
urine samples, ﬁve labs used LC-MS/MS (with LOQs between 0.11 and 1.0 mg/L),
while one lab used GC-(ECNI)MS with an LOQ of 0.2 mg/L. Laboratories reported
their results as total urinary BPA (after enzymatic hydrolysis). However, quality
assurance was set to monitor both total and free BPA to check for possible blank
issues by free BPA. More details on the participating laboratories and the speciﬁc
procedures for quality assurance are presented in Schindler et al. (2014).
2.3. Statistical analysis
Database management and statistical analyses were done with R software
version 2.12.1 (R Development Core Team, 2012) and SAS software version 9.3 (SAS
Institute Inc.). For the individual databases, samples below the limit of quantiﬁca-
tion (LOQ) were replaced by ½ LOQ. The WHO criterion on spot urine samples was
applied, i.e. samples with a creatinine concentration lower than 300 mg/L or higher
than 3000 mg/L were excluded from the analysis (WHO, 1996).
European reference values (geometric means (95% CI) and 90th percentiles) for
BPA were calculated for unadjusted data, and after adjustment for pre-selected
confounders of BPA (creatinine, age and gender for children and creatinine and age
for mothers). These reference values were calculated separately for mothers and
children in mg/L and in mg/g creatinine. To adjust for unequal sample numbers per
country, a weighted geometric mean and a weighted 90th percentile was calcu-
lated. All countries were weighted in such a way that they contributed 120
participants, except Luxembourg that contributed 60 participants per sub-
population. In order to compare the BPA levels among countries, the overall
differences were tested in multiple regression models (based on F-test), either
with and without inclusion of confounders. If an overall signiﬁcant difference was
observed (po0.05), further testing was done by comparing the mean in each
member state with the mean “European reference value” by using multiple
regression models, both with and without inclusion of confounders.
In order to identify determinants of exposure, in the ﬁrst step, univariate
models were developed for selected confounders and covariates (Table 1). In the
second step, multiple regression models were built including those determining
factors which are signiﬁcant at the 0.25 signiﬁcance level in the univariate analyses
and pre-speciﬁed confounders ﬁxed into the model. The ﬁnal models were selected
by stepwise selection procedures, in which “p” was set at 0.05 for a variable to stay
in the model. Linear mixed models were used to take into account the clustered
design of sampling within member states.
The assumption of normality was checked with informal diagnostic residual
plots and the Kolmogorov–Smirnov test (Neter et al., 1996). Inﬂuence diagnostics
(e.g. restricted likelihood distance, Cook's D, and CovRatio) were used to quantify
the inﬂuence of one or more observations by computing parameters estimates
based on all data points, removing the cases in question from the data, reﬁtting the
model, and computing statistics based on the change between full-data and
reduced-data estimates (Fox, 1991). Simple plots were produced (child in Y-axis
and mothers in X-axis) for BPA in the same units for mothers and children.
Spearman correlation coefﬁcients were calculated.
3. Results and discussion
3.1. Description of study population
The basic characteristics of the participating children and their
mothers for the six European countries are given in Table 1.
Within the study population of the children, there was an equal
distribution between boys and girls (50.1% vs. 49.9%) and between
the different age groups (48.6% from 5 to 8 years vs. 51.4% from
9 to 12 years). Also, with respect to area, there was a near equal
distribution between rural (50.7%) and urban (49.3%) samples
(Table 1). The good equilibrium among gender classes, age groups
and area demonstrates that the stratiﬁcation strategy was success-
fully applied by all member states. More than 40% of the mothers
(41.8%) were above 40 years, showing that in several countries, the
inclusion criterion of a maximum age of 45 years was a difﬁcult
target to reach. The oldest mother sampled was 52 year. The body
mass index distribution of mothers was in accordance with the
expected data for a young to medium-age female population, with
70.4% of the mothers having a body mass index (BMI)o25 kg/m².
Table 1
Descriptive statistics of children (n¼653) and mothers (n¼639) from six European member states.
Children (n¼653) Mothers (n¼639)
Categories N (%) Categories N (%)
Gender Boy 327 (50.1%) Woman 639 (100%)
Girl 326 (49.9%)
Age 5–8 years 317 (48.6%) r35 years 93 (14.6%)
9–12 years 335 (51.4%) 35–40 years 279 (43.7%)
4 40 years 267 (41.8%)
Body mass index BMIo15 kg/m² 165 (26.3%) Normal weight (BMIo25 kg/m²) 442 (70.4%)
BMI: 15–17 kg/m² 227 (36.2%) Overweight (BMI: 25–30 kg/m²) 123 (19.6%)
BMIZ17 kg/m² 235 (37.5%) Obesity (BMIZ30kg/m²) 62 (10.0%)
Area of residence Rural 331 (50.7%) Rural 324 (50.7%)
Urban 322 (49.3%) Urban 315 (49.3%)
Highest educational level of the family Primary (ISCED 0–2) 47 (7.2%) Primary (ISCED 0–2) 46 (7.2%)
Secondary (ISCED 3–4) 136 (20.9%) Secondary (ISCED 3–4) 132 (20.7%)
Tertiary (ISCED 5–6) 469 (71.9%) Tertiary (ISCED 5–6) 460 (72.1%)
First-morning urine samples Yes 646 (98.9%) Yes 627 (98.1%)
No 7 (1.1%) No 12 (1.9%)
Period of urine samplinga o10 h 235 (36.4%) o7 h 188 (30.1%)
10–11 h 235 (36.4%) 7–9 h 341 (54.6%)
Z11 h 175 (27.1%) Z9 h 96 (15.4%)
Urinary creatinine (mg/L) N 1842 N 1839
Median 1053 Median 1163
P25–75 784–1426 P25–75 781–1618
Min–Max 10–3120 Min–Max 57–3670
Smoking habits Smoker 0 (0%) Daily smoker 70 (11.0%)
Non-smoker 653 (100%) Occasional smoker 30 (4.7%)
Former smoker 164 (25.7%)
Never smoker 375 (58.7%)
Consumption of canned food Several times/month 84 (17.4%) Several times/month 101 (21.2%)
Once a month or less 398 (82.6%) Once a month or less 376 (78.8%)
Consumption of convenience food in last 24 h Yes 241 (37.5%) Yes 267 (42.6%)
No 401 (62.5%) No 360 (57.4%)
P25: 25th percentile; P75: 75th percentile; N: number; ISCED: International Standard Classiﬁcation of Education.
a Period of time between the last urination and the sample collection.
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The vast majority of the urine samples that were collected
(98.9% in children and 98.1% in mothers) were ﬁrst morning urine
samples; the others were spot urines that were collected through-
out the day. In the initial protocol, measurement of the total
volume of the urine samples was foreseen. However, in several
countries, the information on volume was not reliable because
sample containers were too small and thus did not represent the
volumes of the morning urination. Therefore, the data on volume
were not used in the analysis.
None of the children in the study population were smokers, or
at least they reported that they did not smoke. 15.7% of the
mothers were current smokers, i.e. 11.0% smoked daily and 4.7%
occasionally. Smoking habits in mothers differed considerably by
country, with low proportions (o10%) of current smokers in
Luxembourg (8.3%) and Belgium (9.3%), but high proportions
(430%) in Spain (36.6%). About one ﬁfth of the participants
(17.4% of the children and 21.2% of the mothers) reported to eat
canned food several times per month, while 37.5% of the children
and 42.6% of the mothers had consumed convenience food in the
last 24 h.
3.2. Comparison within and outside Europe
The raw, unadjusted data per member state for children and
mothers are given in Table 2 and Table SI-1. The LOQs in the
different countries ranged from 0.11 to 1 mg/L. The proportion of
values 4LOQ (or the detection frequency) was 490% in 5 out of
6 countries; it was around 50% in Luxembourg, the country with
the highest LOQ, i.e. 1 mg/L. The linear regression model assump-
tions of normality, constancy of variance and independence were
checked and were fulﬁlled for the ﬁnal models without inﬂuential
outliers both for children and adults.
To allow a statistical comparison of the data, the geometric
mean of each individual member state was compared with the
European mean (based on six countries). In this comparison, data
were weighted for an equal number of participants in each
country (120, except 60 in Luxembourg). Comparisons were
performed for BPA expressed in mg/L and in mg/g creatinine, both
on unadjusted data and after adjustment for confounders (age,
gender (þurinary creatinine for data in mg/L) in children; age
(þurinary creatinine for data in mg/L) in mothers). Results in both
units, and without or with adjustment, gave very similar results,
both in children and in mothers.
Overall, there was a low inter-individual variability in urinary
BPA levels: i) the distribution within a country was narrow; ii)
levels were quite similar in children and in mothers; and iii) the
average levels in the different countries were very close together
(ratio between highest and lowest geometric mean was 1.8 in
children and 2.0 in mothers). Yet, signiﬁcant differences were
observed between countries (Table 2, Table SI-1). In children,
compared to the European mean, signiﬁcantly higher values were
observed in Slovenia and signiﬁcantly lower levels were found in
Sweden (Table 2, Fig. 1). For the mothers, signiﬁcantly higher
concentrations were observed in Belgium and Denmark, while
levels in Sweden and Slovenia were signiﬁcantly lower (Table 2,
Fig. 1). Thus, the conclusions in both age groups are to some extent
consistent (e.g. for Sweden), but also contradictory (e.g. for
Slovenia). We may speculate that the correlation between mothers
and children will be high in case the major source of BPA is a
common life style factor such as the food consumption pattern of
the family, but the correlation will be weaker if exposure to BPA is
rather determined by individual habits such as use of medication,
consumption of convenience food or use of different types of
packing material, which may differ between children and mothers.
Table 2
Results of urinary BPA (mg/L) per member state in children and their mothers, unadjusted data.
Member state N LOQ %4LOQ GM (95% CI) Min. P10 P25 P50 P75 P90 P95 Max.
Children (lg/L)
All 653 0.11–1.00 91.1 1.97 (1.81–2.15) oLOQ 0.60 1.05 1.96 3.76 7.36 13.14 821.90
Belgium 125 0.20 96.8 2.35 (1.92–2.87) oLOQ 0.76 1.40 2.27 3.76 8.15 13.44 445.24
Denmark 142 0.12 90.8 1.87 (1.53–2.29) oLOQ 0.63 1.09 1.71 3.42 6.20 7.90 821.90
Luxembourg 59 1.00 52.5 1.78 (1.34–2.37) oLOQ oLOQ oLOQ 1.38 3.33 5.72 8.28 18.54
Slovenia 112 0.11 92.9 2.63 (2.15–3.22) oLOQ 0.69 1.47 3.30 5.71 14.87 18.86 31.43
Spain 118 0.20 95.8 1.83 (1.50–2.24) oLOQ 0.42 1.10 1.91 3.59 7.36 9.84 21.60
Sweden 97 0.15 100.0 1.48 (1.21–1.81) 0.35 0.58 0.90 1.31 2.22 4.14 6.24 32.40
Mothers (lg/L)
All 639 0.11–1.00 90.5 1.78 (1.62–1.94) oLOQ 0.46 1.00 1.94 3.70 6.70 11.13 455.62
Belgium 125 0.20 100.0 2.55 (2.07–3.15) 0.30 0.89 1.41 2.30 3.94 7.47 11.63 455.62
Denmark 143 0.12 90.9 2.00 (1.62–2.47) oLOQ 0.45 1.00 2.10 4.16 8.65 11.45 105.84
Luxembourg 56 1.00 44.6 1.63 (1.21–2.19) oLOQ oLOQ oLOQ oLOQ 2.69 5.58 7.44 9.78
Slovenia 106 0.11 81.7 1.37 (1.11–1.69) oLOQ oLOQ 0.49 1.97 3.99 7.72 13.35 69.75
Spain 113 0.20 96.5 2.04 (1.65–2.52) oLOQ 0.41 1.01 2.26 5.08 8.64 12.15 39.80
Sweden 96 0.15 100.0 1.30 (1.05–1.60) 0.23 0.47 0.79 1.29 2.18 3.50 5.02 6.34
LOQ¼ limit of quantiﬁcation; GM¼geometric mean; 95% CI: 95% conﬁdence interval; min.¼minimum; and max.¼maximum.
Fig. 1. Mean urinary BPA concentration in six countries in comparison with the
European reference value. Data are geometric means (95% CI) in mg/L, after
adjustment for urinary creatinine and age in mothers, and additional adjustment
for gender in children. ALL: six countries; BE: Belgium; DK: Denmark; ES: Spain;
LU: Luxembourg; SE: Sweden; and SL: Slovenia. The overall p-Value (ANOVA):
po0.0001 in mothers; p¼0.04 in children. Post-hoc analysis: each country is
compared with the European reference value (ALL); npo0.05; nnpo0.01; and
nnnpo0.001.
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In children, the weighted geometric mean (95% CI) for urinary
BPA equaled 1.97 (1.81–2.15) mg/L and 1.95 (1.80–2.13) mg/g
creatinine in the total European study group. In mothers, the
weighted geometric mean (95% CI) equaled 1.78 (1.62–1.94) mg/L
and 1.65 (1.51–1.79) mg/g creatinine (Table SI-1), suggesting a
tendency for higher levels in children compared to their mothers.
The ‘raw’ 90th percentile (based on six countries) for urinary
BPA equaled 7.36 (95% CI: 6.17–8.77) mg/L and 7.05 (95% CI: 5.97–
8.33) mg/g creatinine in children and 6.70 (95% CI: 5.73–7.83) mg/L
and 6.03 (95% CI: 5.19–6.99) mg/g creatinine in mothers. The
weighted 90th percentile was 7.36 (95% CI: 6.24–8.68) mg/L and
7.05 (5.94–8.38) mg/g creatinine in children and 6.56 mg/L (5.59–
7.70) and 5.85 (5.03–6.80) mg/g creatinine in mothers. The 90th
percentiles of the individual countries give similar information as
the average values (Table SI-2), suggesting that the distributions
are comparable between the different countries. Clearly the
differences in the LOQs of the analytical methods used in the
different countries did not affect the distribution of the BPA values.
Several HBM studies in children and adults have been conducted
in Europe, North America, and Asia, revealing the worldwide
exposure to BPA (Table 3). BPA had a high detection frequency in
all studies, with most of the values being 490% throughout the
studies. Also there were no clear differences in the levels in a
particular country or continent (Table 3). When different age groups
were investigated, the urinary levels of BPA tended to be higher in
the youngest age category. In the US NHANES 2003–2004 study, the
highest BPA levels were measured in adolescents (12–19 years),
followed by children (6–11 years) and adults (419 years) (Calafat
et al., 2008). However, the creatinine adjustment led to the highest
BPA concentrations in children, followed by adolescents and adults
(Calafat et al., 2008). In a Canadian study (Bushnik et al., 2010), BPA
levels adjusted for creatinine were higher in the youngest age group
(6–11 years) than in the other age categories. Similarly, German
children in the youngest age category (3–5 years) had higher urinary
BPA levels than children from other age categories (6–8 years, 9–11
years, and 12–14 years) (Becker et al., 2009) and in Denmark
signiﬁcantly higher levels were observed in children (6–10 years)
compared to both older children (11–15 years) and adolescents (16–
21 years) (Frederiksen et al., 2013a).
3.3. Urinary BPA: determinants of exposure
The relationships between BPA levels and covariates resulting
from univariate regression models are given in Table SI-3 for
children and in Table SI-4 for mothers. Only weak associations
were found; this might be partly explained by a lack of power due
the relatively low sample numbers in each country, by the low
variability in BPA levels, and by the difﬁculty to capture the factors
of inﬂuence using a rather general questionnaire. It should be
pointed out that DEMOCOPHES was a survey which aimed at
demonstrating the feasibility of harmonizing human biomonitor-
ing across countries.
For children, signiﬁcantly higher values were observed in
younger children, i.e. geometric means (95% CI) equaled 2.15
(1.90–2.44) mg/g creatinine (crt) in 6–8 year old children vs. 1.80
(1.61–2.02) mg/g crt (p¼0.04) in 9–11 year old children. Also, a
signiﬁcant effect (p¼0.03) of educational level was observed in
children, with higher values in children from families with primary
education (2.59 (2.03–3.30) mg/g crt) compared to children from
families with secondary (1.64 (1.32–2.04) mg/g crt) and tertiary
education (2.01 (1.83–2.21) mg/g crt). In the multivariate models, a
signiﬁcant relationship was found between BPA levels in urine and
urinary creatinine. The other variables (age and gender) were not
signiﬁcant. Educational level was borderline signiﬁcant (p¼0.04),
but the interpretation was not clear (Table 4). Possibly, the associa-
tion between the urinary BPA levels and educational/social class
is country dependent. While Ye et al. (2008) documented higher
urinary BPA levels in the higher social class in a female Dutch
population, the opposite has been seen in the general US population
of NHANES 2003–2004 (Calafat et al., 2008) and a female Mexican
population (Cantonwine et al., 2010).
The BPA levels in the mothers (both in mg/L or mg/g crt)
correlated poorly but signiﬁcantly with the BMI of the mother
(as continuous or categorical variable – normal weight, overweight
and obesity). The various correlations ranged 0.08oro0.11,
po0.05, n¼628). When BMI is included in the multiple regression
model, the association lost its signiﬁcance.
Mothers who consumed canned food several times per week had
signiﬁcantly higher urinary BPA levels compared to mothers who
consumed canned food once a week or less, i.e. the geometric mean
(95% CI) equaled 2.34 (1.88–2.91) mg/g crt vs. 1.77 (1.61–1.95) mg/g crt;
p¼0.03. In multiple models, a signiﬁcant relationship was observed
with urinary creatinine (higher BPA values for higher creatinine
levels; po0.0001); time period from the last urination before urine
collection (higher BPA levels with increasing collection periods;
p¼0.02); age of the mother (higher levels in older mothers;
p¼0.002) and borderline non-signiﬁcant with consumption of
canned food (higher levels in frequent consumers; p¼0.05) (Table 4).
As a sensitivity analysis, the same multiple regression models
were applied using weighting factors to adjust for the unequal
sample sizes between the countries. Both in children and in
mothers, the conclusions remained the same after weighting.
Other studies have also reported the inﬂuence of diet on the
urinary concentrations of BPA. Quiros-Alcala et al. (2013) showed
that women who consumed more than 3 ﬁzzy drinks per day or
hamburgers three times or more per week had 58% and 20%
higher urinary BPA concentrations, respectively, compared with
women who consumed no ﬁzzy drinks or hamburgers. Casas et al.
(2013) indicated that pregnant women who were younger, less-
educated, smoked, and who were exposed to second-hand tobacco
smoke (SHS) had higher urinary BPA concentrations than others.
BPA concentrations were also higher in children exposed to SHS.
High consumption of canned ﬁsh during pregnancy was associated
with 21% and 25% higher urinary BPA concentrations in the ﬁrst
and third pregnancy trimester, respectively, compared to the
lowest consumption group. Further evaluation of speciﬁc BPA
exposure sources in the socio-demographic group of women
who smoke, are exposed to SHS, and have a low educational level
is needed. Studies identifying sources of exposure would beneﬁt
from repeat BPA measurements and should use questionnaires
speciﬁcally focused on dietary sources.
3.4. Urinary BPA: correlation between children and mothers
Spearman correlation coefﬁcients were calculated between the
individual urinary BPA levels of the mothers and the children. In total,
621 mother–child pairs had measurements of urinary BPA and were
included in the analysis. The correlation between individual BPA levels
in mothers and in children (in mg/L) was signiﬁcant (r¼0.456,
po0.001). Even when excluding the two extreme outliers, this
correlation remained signiﬁcant (r¼0.233, po0.001) (Fig. SI-1). The
geometric means of BPA levels (in mg/L) in each country correlated
strongly between mothers and children (r¼0.96, po0.001) (Fig. 2),
after Slovenia was excluded as it did not follow the trends observed in
the other ﬁve countries. The remarking difference between children
and mothers could provide an opportunity to identify possible sources
of children's exposure. However, none of the characteristics of the
children, either related to food intake (canned food, convenience food,
canteen food, etc.), to urine sampling (duration of collection, volume,
etc.) or other study parameters deviated strongly. Therefore, the
explanatory factor for the high value in children is one beyond those
that are currently under investigation.
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Table 3
Overview of worldwide biomonitoring studies for BPA concentrations in urine (mg/L or mg/g crt) and BPA intake (95% CI) (ng/kg body weight per day).
Country Population Concentration (lg/L or lg/g
crt)
Intake GM (95% CI) (ng/kg bw per
day)
Det. freq.
(%)
References
Belgium 125 (6–11 years) GM 2.35 mg/L (2.10 mg/g crt) 41.2 (32.9–51.7) 97 This study
125 (27–45 years) GM 2.55 mg/L (2.28 mg/g crt) 39.5 (33.3–46.8) 100
Denmark 142 (6–11 years) GM 1.87 mg/L (1.94 mg/g crt) 38.9 (32.2–47.0) 91 This study
143 (31–52 years) GM 2.00 mg/L (2.05 mg/g crt) 35.7 (29.9–42.6) 91
Luxembourg 59 (6–11 years) GM 1.78 mg/L (1.78 mg/g crt) 35.2 (27.3–45.3) 53 This study
56 (33–45 years) GM 1.63 mg/L (1.75 mg/g crt) 30.0 (24.7–36.3) 45
Slovenia 112 (6–12 years) GM 2.63 mg/L (2.19 mg/g crt) 41.4 (31.7–54.2) 93 This study
106 (30–46 years) GM 1.37 mg/L (1.04 mg/g crt) 18.1 (13.2–24.7) 88
Spain 118 (6–11 years) GM 1.83 mg/L (2.01 mg/g crt) 38.3 (31.4–46.7) 96 This study
113 (26–48 years) GM 2.04 mg/L (1.97 mg/g crt) 32.7 (26.8–39.8) 97
Sweden 97 (6–11 years) GM 1.48 mg/L (1.67 mg/g crt) 32.6 (27.8–38.3) 100 This study
966 (28–46 years) GM 1.30 mg/L (1.22 mg/g crt) 21.2 (18.7–24.1) 100
The Netherlands 100 (18–41 years) preg
women
GM 1.5 mg/L (1.7 mg/g crt) GM 24, median 19 82 Ye et al. (2008)
Germany 137 (3–5 years) GM 3.55 mg/L, median
3.53 mg/L
60 (all ages) 99 Becker et al. (2009)
145 (6–8 years) GM 2.72 mg/L, median
2.81 mg/L
99
149 (9–11 years) GM 2.22 mg/L, median
2.13 mg/L
99
168 (12–14 years) GM 2.42 mg/L, median
2.60 mg/L
98
600 (20–30 years) GM 1.55 mg/L (1.76 mg/g crt) 39 (37–42) 99.8 Koch et al. (2012)
104 (6–8 years) children GM 2.4 mg/L (2.3 mg/g crt) – 100 Kasper-Sonnenberg et al.
(2012)104 (29–49) mothers GM 2.1 mg/L (1.8 mg/g crt) – 100
Denmark 129 (all 6–21 years) GM 1.03 mg/L, median 1.37 mg/L 37.7 (30.4–46.9) 83 Frederiksen et al. (2013a)
49 (6–10 years) GM 2.05 mg/L, median
2.78 mg/L
56.4 (41.0–77.6) 94
55 (11–16 years) GM 0.69 mg/L, median
0.81 mg/L
28.6 (20.2–40.5) 75
25 (17–21 years) GM 0.65 mg/L, median
0.76 mg/L
26.5 (16.1–43.7) 80
309 (18–27 years) men GM 3.09 mg/L, median
3.23 mg/L
98 Frederiksen et al. (2014)
565 (19–42 years) preg
women
GM 1.17 mg/L, median 1.52 mg/L 90
Belgium 193 (14–16 years) GM 2.22 mg/L (1.66 mg/g crt) 40 99 Schoeters et al. (2011)
Italy 111 (20–40 years) GM 4.31 mg/L 75 Galloway et al. (2010)
157 (41–65 years) GM 3.95 mg/L 69
452 (66–74 years) GM 3.32 mg/L 58
Spain 30 (boys 4 years) Median 4.2 mg/L 97 Casas et al. (2011)
120 pregnant women Median 2.2 mg/L 35 91
US 394 (418 years) GM 1.33 mg/L (1.36 mg/g crt) 23 95 Calafat et al., 2005
US 90 (girls 6–8 years) GM 2.0 mg/L (3.0 mg/g crt) 33 94.4 Wolff et al. (2007)
US 35 (6–10 years) GM 3.4 mg/L (3.4 mg/g crt) 57 95 Teitelbaum et al. (2008)
US 314 (6–11 years) GM 3.6 mg/L (4.3 mg/g crt) 65 93 Calafat et al. (2008)
713 (12–19 years) GM 3.7 mg/L (2.8 mg/g crt) 71
950 (20–59 years) GM 2.6 mg/L (2.4 mg/g crt) 46
537 (Z 60 years) GM 1.9 mg/L (2.3 mg/g crt) 34
US 81 (1–5 years) GM 4.8 mg/L (6.6 mg/g crt) 111 100 Morgan et al. (2011)
Canada 6–11 years GM 1.30 mg/L (2.00 mg/g crt) 25 93 Bushnik et al. (2010)
12–19 years GM 1.50 mg/L (1.31 mg/g crt) 31 94
20–39 years GM 1.33 mg/L (1.49 mg/g crt) 26 91
40–59 years GM 1.04 mg/L (1.33 mg/g crt) 20 88
60–79 years GM 0.90 mg/L (1.26 mg/g crt) 17 88
Mexico 60 preg women GM 1.95 mg/L 34 80 Cantonwine et al. (2010)
Korea 516 Median 0.64 mg/L 55 76 Hong et al. (2009)
China 419 males GM 1.41 mg/L (0.72 mg/g crt) 32 58 He et al. (2009)
503 females GM 0.58 mg/L (0.23 mg/g crt) 10 44
China 287 (3–24 years) GM 3.0 mg/L (2.75 mg/g crt) 60 100 Li et al. (2013)
China 116 (31716 years) GM 1.10 mg/L (1.03 mg/g crt) 90 Zhang et al. (2011)
Vietnam 30 (49718 years) GM 1.42 mg/L (1.27 mg/g crt) 100 Zhang et al. (2011)
Malaysia 29 (3079 years) GM 1.00 mg/L (1.93 mg/g crt) 97 Zhang et al. (2011)
India 21 (45716 y) GM 1.59 mg/L (2.51 mg/g crt) 100 Zhang et al. (2011)
Kuwait 32 (23714 years) GM 1.24 mg/L (1.09 mg/g crt) 81 Zhang et al. (2011)
Japan 36 (32710 years) GM 0.84 mg/L (0.67 mg/g crt) 100 Zhang et al. (2011)
Korea 32 (37711 y) GM 2.00 mg/L (2.53 mg/g crt) 97 Zhang et al. (2011)
All Asian
countries
Children Median 39
Adults Median 37
GM: geometric mean; crt: creatinine.
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3.5. Urinary BPA – comparison with guidance values
The German HBM Commission deﬁnes provisional HBM values
for BPA, i.e. a HBM-I of 1500 mg/L in children and a HBM-I value of
2500 mg/L in mothers (German Human Biomonitoring Commission,
2012). None of the participants had values above the HBM-I guide-
line, neither in children, nor in mothers. Also none of the participants
had urinary concentrations of BPA above the biomonitoring equiva-
lent (BE) value of 2000 mg/L proposed by Aylward et al. (2013). Of
note, the provisional HBM values of the German HBM Commission
have been based upon the EFSA TDI of 50,000 ng/kg bw per day and
do not yet reﬂect the t-TDI of 5000 ng/kg bw per day proposed by
EFSA in 2014, which might lead to lower HBM values.
3.6. Intake of BPA
For estimating the daily BPA intake, BPA concentrations were
adjusted for daily creatinine excretion. This calculation scenario is
based on the approach involving creatinine excretion described by
Frederiksen et al. (2013b), Koch and Calafat (2009) and Wittassek
et al. (2007). The daily intake of BPA assuming steady-state
excretion is calculated using the following equation:
Intake BPA ðmg=kg bw per dayÞ
¼ ½UEcreaðmg=gcreaÞ  CEsmoothedðg=dayÞ=BWðkgÞ ð1Þ
where UEcrea is the urinary concentration of BPA adjusted for
creatinine, BW is the body weight and CEsmoothed is the 24 h
Table 4
Determinants of urinary BPA (mg/L): multiple linear mixed models in children and mothers.
Parameters Strata Estimate (95% CI) for change (multiplicative factor) p-Value Overall p-Value
Children
Number of observations in model: n¼651
Cluster variance: 0.0149 (p¼0.19); residual variance: 1.1946; intra-class correlation coefﬁcient: 1.2295
Urinary creatinine level 300–900 mg/L 0.51 (0.40–0.66) o0.0001 o0.0001
900–1500 mg/L 0.87 (0.68–1.10) 0.23
1500–3000 mg/L 1.00 –
Gender Boys 1.03 (0.87–1.22) 0.73 0.73
Girls 1.00 –
Age 5–8 years 1.09 (0.92–1.30) 0.32 0.32
9–12 years 1.00 –
Educational level of the family Primary 1.24 (0.88–1.76) 0.23 0.04
Secondary 0.81 (0.65–1.00) 0.05
Tertiary 1.00 –
Mothers
Number of observations in model: n¼639
Cluster variance: 0.0559 (p¼0.15); residual variance: 0.9252; intra-class correlation coefﬁcient: 5.69
Urinary creatinine level 300–900 mg/L 0.34 (0.27–0.43) o0.0001 o0.0001
900–1500 mg/L 0.65 (0.52–0.82) o0.0001
1500–3000 mg/L 1.00 –
Age r 35 years 0.66 (0.50–0.87) 0.003 0.002
35–40 years 0.74 (0.61–0.90) 0.003
4 40 years 1.00 –
Urine sampling perioda o7 h 0.72 (0.53–0.97) 0.03 0.02
7–9 h 0.94 (0.70–1.24) 0.64
Z 9 h 1.00 –
Consumption of canned food Several times per week 1.25 (0.998–1.57) 0.05 0.05
Once per week or less 1.00
a Period of time between the last urination and the sample collection.
Fig. 2. Correlation between urinary BPA concentrations in children and in mothers. Data are geometric means. BE: Belgium; DK: Denmark; ES: Spain; LU: Luxembourg; SE:
Sweden; and SL: Slovenia.
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urinary creatinine excretion. CEsmoothed for the mothers is calcu-
lated with the following equation:
CEsmoothedðmg=dayÞ ¼ 1:64 ð140ageðyearÞÞ  BWðkgÞ1:5
heightðcmÞ0:5 ð2Þ
where 1.64 and 140 are constants described by Frederiksen et al.
(2013b) and the individual height, weight and age for each mother
were used. For the children, CEsmoothed corresponded to age and
sex speciﬁc average creatinine excretion levels based on data
provided by Remer et al. (2002): boys aged 6–8 years (0.49 g/
day) or 9–13 years (0.76 g/day) and girls aged 6–8 years (0.45 g/
day) or 9–13 years (0.72 g/day).
The resulting values and the corresponding descriptive statis-
tics for children and mothers are given for each country in Table
SI-5. The geometric mean and CI 95% of BPA intake for the
individual countries resulting from this calculation scenario are
also given in Table 3. The trends in the intake of BPA followed the
trends observed between the various countries in the urinary
concentrations of BPA, with a tendency of higher intakes in
children compared to adults (Table SI-5). The estimated BPA
intakes in the various studies worldwide were very similar
between the countries and continents (Table 3).
Since many factors, such as diurnal variation, changes in the
rate of glomerular ﬁltration, body mass, age, gender, health status,
and external factors, such as diet, exercise, and drug use, con-
tribute to the daily variability in creatinine output, we have
calculated the intake of BPA based on a second scenario. In this
2nd calculation scenario, the urinary concentrations of total BPA
(mg/L) in the spot samples were multiplied with 24 h urinary
output (mL) to obtain the daily excretion of BPA in ng/day. Since
excretion of ingested BPA into urine is essentially complete in 24 h
(Völkel et al., 2002, 2005), this was assumed to be equal to the
daily intake. The estimated intake can be adjusted for body weight
to obtain an exposure expressed in ng/kg bw per day (Lakind and
Naiman, 2008). Fixed volumes were used for the urinary output, e.
g. 600 mL per day for children and 1200 mL per day for mothers
(Lakind and Naiman, 2011). However, also urine volume is related
to several factors such as liquid intake, physical exercise, and
individual health and lifestyle factors. The daily intake of BPA is
calculated using the following equation:
Intake BPAðng=kg bw dayÞ
¼ urinary conc BPAðng=mLÞ  urinary outputðmL=dayÞ=BWðkgÞ
ð3Þ
Remarkably, there were very little differences observed in the
BPA intakes obtained using the two calculation scenarios (Table SI-
5), suggesting the correctness of both approaches. Indeed, overall
geometric means of the BPA intake of all countries (95% CI) for the
assessment via creatinine output were 38.2 (35.0–41.7) and 29.1
(26.7–31.7) ng/kg body weight per day for children and mothers,
respectively, while for the assessment via ﬁxed urinary output,
they were 38.9 (35.5–42.6) and 33.6 (30.6–36.8) ng/kg body
weight per day for children and mothers, respectively.
Daily intake calculations based on biomonitoring data allow the
direct comparison of individual exposures with the tolerable daily
intake of 50,000 ng/kg bw per day. None of the participants had an
estimated BPA intake higher than the TDI (Table SI-5). Although
these dose calculations are performed using certain assumptions
(e.g. daily urine volume or creatinine excretion, uniform metabo-
lism), they reﬂect real exposures, where all possible exposure
sources are included. However, an important outcome of these
calculations is that maximum daily intakes are below the current
TDI for BPA, but may exceed the newly proposed EFSA TDI of
5000 ng/kg bw per day. In other studies (summarized in Geens
et al. (2012)), worst-case scenarios for young children estimated
intakes of up to 11–13,000 ng/kg bw per day, which is very well in
agreement with the data in this paper.
In conclusion, the current study shows that BPA exposure in
Europe is widespread; in ﬁve out of six countries, more than 87%
of the individuals are exposed to BPA above the LOQ. The
“European reference values” of BPA showed no large differences
in the urinary levels among European citizens, and among age
groups. Although the current study did not focus on dietary intake,
canned food consumption was an inﬂuencing factor for the
mothers' levels.
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